← All indications
Ureterolithiasis
Formation of stones in the URETER.
Subtype terms (1)
More specific conditions that are subtypes of Ureterolithiasis in the MeSH hierarchy.
- Ureteral Calculi
14 drugs (12 approved, 2 experimental)
Drugs by status
Phase 4 trials (2)
Phase 3 trials (1)
Phase 2 trials (1)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (25)
- Pfizer
- JW Pharmaceutical
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Inje University
- Mansoura University
- McMaster University
- Ilsan Hospital
- Pontificia Universidad Catolica de Chile
- Kangbuk Samsung Hospital
- University of Minnesota
- Emek Medical Center
- Beni Suef University
- Technion University
- Eulji University
- University of Sao Paulo
- Chiangmai University
- University of Sherbrooke
- University of Western Ontario
- George Washington University
- Yeshiva University
- University of Helsinki
- The Cleveland Clinic
- Seonam University
- University Clermont Auvergne
- King Abdul-Aziz University
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (5)